Chunxi Yan
Overview
Explore the profile of Chunxi Yan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Y, Liu L, Li M, Wang S, Fu J, Yang M, et al.
Sci Rep
. 2025 Jan;
15(1):3063.
PMID: 39856116
Polyetheretherketone (PEEK) is widely used in orthopedic and dental implants due to its excellent mechanical properties, chemical stability, and biocompatibility. However, its inherently bioinert nature makes it present weak osteogenic...
2.
Wang F, Wang L, Yan C, Chang X, Wang H, Zhu K, et al.
Rev Cardiovasc Med
. 2024 Jul;
24(10):281.
PMID: 39077587
Background: Various electrocardiographic (ECG) abnormalities are associated with the severity of pulmonary thromboembolism (PTE). The utility of evaluating the clot burden of PTE based on ECG findings alone has yet...
3.
Ma T, Huang R, Xu Y, Lv Y, Liu Y, Pan X, et al.
J Transl Med
. 2023 Jan;
21(1):21.
PMID: 36635690
Background: Growth arrest-specific 6 (GAS6) is a vitamin K-dependent protein related to inflammation, fibrosis, as well as platelet function. Genetic ablation of GAS6 in mice protects against cardiac hypertrophy and...
4.
Su Y, Sun Y, Tang Y, Li H, Wang X, Pan X, et al.
J Am Heart Assoc
. 2021 Oct;
10(20):e022304.
PMID: 34612058
Background Circulating microRNAs are emerging biomarkers for heart failure (HF). Our study aimed to assess the prognostic value of microRNA signature that is differentially expressed in patients with acute HF....
5.
Zhu K, Ma T, Su Y, Pan X, Huang R, Zhang F, et al.
Front Cardiovasc Med
. 2021 Aug;
8:683418.
PMID: 34368245
This review summarizes current knowledge regarding clinical epidemiology, pathophysiology, and prognosis for patients with HFmrEF in comparison to HFrEF and HFpEF. Although recommended treatments currently focus on aggressive management of...
6.
Su Y, Ma M, Zhang H, Pan X, Zhang X, Zhang F, et al.
Exp Ther Med
. 2020 Sep;
20(5):101.
PMID: 32973950
Hyponatremia is a risk factor associated with poor prognosis in patients with heart failure (HF) with reduced ejection fraction. However, whether hyponatremia has a similar role in patients with HF...
7.
Su Y, Ma T, Wang Z, Dong B, Tai C, Wang H, et al.
ESC Heart Fail
. 2020 Sep;
7(6):4465-4471.
PMID: 32945150
Aims: Elevated heart rate (HR) in heart failure (HF) is associated with worse outcomes, particularly in acute HF (AHF). HR reduction with ivabradine reduces cardiovascular events in HF patients with...